Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ainoleena Turku

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal of Chemical Information and Modeling|December 23, 2024
SpaceHASTEN: A Structure-Based Virtual Screening Tool for Nonenumerated Virtual Chemical LibrariesTuomo Kalliokoski, Ainoleena Turku, Heikki Käsnänen
BMC Structural Biology|May 10, 2015
Modeling of the OX1R-orexin-A complex suggests two alternative binding modesLasse Karhu, Ainoleena Turku, Henri Xhaard
Molecular Pharmacology|October 9, 2019
Molecular Pharmacology of Class F Receptor ActivationPawel Kozielewicz, Ainoleena Turku, Gunnar Schulte
Molecular Pharmacology|November 11, 2019
A NanoBRET-Based Binding Assay for Smoothened Allows Real-time Analysis of Ligand Binding and Distinction of Two Binding Sites for BODIPY-cyclopaminePaweł Kozielewicz, Carl-Fredrik Bowin, Ainoleena Turku, et al.
Biosensors & Bioelectronics|January 24, 2021
Deconvolution of WNT-induced Frizzled conformational dynamics with fluorescent biosensorsHannes Schihada, Maria Kowalski-Jahn, Ainoleena Turku, et al.
Nature Communications|June 25, 2021
Residue 6.43 defines receptor function in class F GPCRsAinoleena Turku, Hannes Schihada, Pawel Kozielewicz, et al.
Journal of Medicinal Chemistry|August 23, 2016
Pharmacophore Model To Discover OX1 and OX2 Orexin Receptor LigandsAinoleena Turku, Alexandre Borrel, Teppo O Leino, et al.
Science Advances|November 10, 2021
Frizzled BRET sensors based on bioorthogonal labeling of unnatural amino acids reveal WNT-induced dynamics of the cysteine-rich domainMaria Kowalski-Jahn, Hannes Schihada, Ainoleena Turku, et al.
Plos One|June 3, 2017
Orexin receptor agonist Yan 7874 is a weak agonist of orexin/hypocretin receptors and shows orexin receptor-independent cytotoxicityAinoleena Turku, Maiju K Rinne, Gustav Boije Af Gennäs, et al.
European Journal of Medicinal Chemistry|August 6, 2018
Azulene-based compounds for targeting orexin receptorsTeppo O Leino, Ainoleena Turku, Jari Yli-Kauhaluoma, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of Chemical Information and Modeling|December 23, 2024
SpaceHASTEN: A Structure-Based Virtual Screening Tool for Nonenumerated Virtual Chemical LibrariesTuomo Kalliokoski, Ainoleena Turku, Heikki Käsnänen
BMC Structural Biology|May 10, 2015
Modeling of the OX1R-orexin-A complex suggests two alternative binding modesLasse Karhu, Ainoleena Turku, Henri Xhaard
Molecular Pharmacology|October 9, 2019
Molecular Pharmacology of Class F Receptor ActivationPawel Kozielewicz, Ainoleena Turku, Gunnar Schulte
Molecular Pharmacology|November 11, 2019
A NanoBRET-Based Binding Assay for Smoothened Allows Real-time Analysis of Ligand Binding and Distinction of Two Binding Sites for BODIPY-cyclopaminePaweł Kozielewicz, Carl-Fredrik Bowin, Ainoleena Turku, et al.
Biosensors & Bioelectronics|January 24, 2021
Deconvolution of WNT-induced Frizzled conformational dynamics with fluorescent biosensorsHannes Schihada, Maria Kowalski-Jahn, Ainoleena Turku, et al.
Nature Communications|June 25, 2021
Residue 6.43 defines receptor function in class F GPCRsAinoleena Turku, Hannes Schihada, Pawel Kozielewicz, et al.
Journal of Medicinal Chemistry|August 23, 2016
Pharmacophore Model To Discover OX1 and OX2 Orexin Receptor LigandsAinoleena Turku, Alexandre Borrel, Teppo O Leino, et al.
Science Advances|November 10, 2021
Frizzled BRET sensors based on bioorthogonal labeling of unnatural amino acids reveal WNT-induced dynamics of the cysteine-rich domainMaria Kowalski-Jahn, Hannes Schihada, Ainoleena Turku, et al.
Plos One|June 3, 2017
Orexin receptor agonist Yan 7874 is a weak agonist of orexin/hypocretin receptors and shows orexin receptor-independent cytotoxicityAinoleena Turku, Maiju K Rinne, Gustav Boije Af Gennäs, et al.
European Journal of Medicinal Chemistry|August 6, 2018
Azulene-based compounds for targeting orexin receptorsTeppo O Leino, Ainoleena Turku, Jari Yli-Kauhaluoma, et al.
Pageof 3